Lichen International (LICN) Debt to Equity (2021 - 2023)

Lichen International (LICN) reported Debt to Equity of $0.03 for Q4 2023, down 50.21% year-over-year from $0.05 in Q4 2022, and up 227.98% quarter-over-quarter from -$0.02 in Q2 2023.

Lichen International (LICN) Debt to Equity (2021 - 2023) Analysis & Trends

Lichen International (LICN) has 3 years of Debt to Equity data on file, last reported at $0.03 in Q4 2023.

  • Debt to Equity for Q4 2023 came in at $0.03, down 50.21% year-over-year; the trailing twelve-month figure through Dec 2023 was $0.03 (down 50.21% YoY), and the FY2023 annual result was $0.03, down 50.21% from the prior year.
  • Debt to Equity advanced to $0.03 in Q4 2023 per LICN's latest filing, from -$0.02 in the prior quarter.
  • Over five years, Debt to Equity peaked at $0.05 in Q4 2022 and troughed at -$0.02 in Q2 2023.
  • A 3-year average of $0.02 and a median of $0.02 in 2021 frame the typical range for Debt to Equity.
  • The sharpest annual moves came in 2022 and 2023: Debt to Equity soared 454.72% in 2022, then sank 50.21% in 2023.
  • A 3-year view of Debt to Equity shows it stood at $0.01 in 2021, then soared by 454.72% to $0.05 in 2022, then tumbled by 50.21% to $0.03 in 2023.
  • Business Quant data shows LICN's Debt to Equity at $0.03 in Q4 2023, -$0.02 in Q2 2023, and $0.05 in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Cintas 70.95 Bn 70.77 Bn 1.45 Bn 0.55
2 Copart 29.43 Bn 26.09 Bn 1.08 Bn -
3 Rb Global 20.04 Bn 19.85 Bn 869.50 Mn 0.45
4 UL Solutions 19.54 Bn 19.30 Bn 381.00 Mn 0.27
5 Global Payments 18.52 Bn 13.33 Bn 1.70 Bn 0.92
6 Aramark 14.28 Bn 13.87 Bn 426.35 Mn 1.86
7 Relx 11.84 Bn 11.60 Bn - -
8 Amentum Holdings 5.58 Bn 5.67 Bn 345.00 Mn 0.83
9 Dolby Laboratories 5.00 Bn 4.42 Bn 350.90 Mn -
10 Lichen International 14.53 Mn -12.39 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2023 0.03
Jun 30, 2023 -0.02
Dec 31, 2022 0.05
Dec 31, 2021 0.01